COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 380: Articles 3791-3800  | Next

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains
Moldovan Loomis, C., Lahlali, T., Van Citters, D., Sprague, M., Neveu, G., Somody, L., Siska, C. C., Deming, D., Asakawa, A. J., Amimeur, T., Shaver, J. M., Carbonelle, C., Ketchem, R. R., Alam, A., Clark, R. H.
10.1101/2023.08.21.554197 — Posted: 2023-08-22
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation
Hauser, B. M., Sangesland, M., Lam, E. C., St. Denis, K. J., Sheehan, M. L., Vu, M. L., Cheng, A. H., Balazs, A. B., Lingwood, D., Schmidt, A.
10.1101/2023.08.21.554179 — Posted: 2023-08-22
Enhancing t-SNE Performance for Biological Sequencing Data through Kernel Selection
Chourasia, P., Murad, T., Ali, S., Patterson, M.
10.1101/2023.08.21.554138 — Posted: 2023-08-22
Post-COVID rebound of gonorrhoea in England
Fountain, H., Migchelsen, S., Charles, H., Ram, T., Fifer, H., Mohammed, H., Sinka, K.
10.1101/2023.08.18.23294107 — Posted: 2023-08-22
Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha
Faucher, B., Sabbatini, C. E., Czuppon, P., Kraemer, M. U. G., Lemey, P., Colizza, V., Blanquart, F., Boelle, P.-Y., Poletto, C.
10.1101/2023.08.21.23293488 — Posted: 2023-08-22
Study of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans suggests a North African origin for Neanderthals
El Youssfi, F. Z., Haroun, A. E., Nebhani, C., Belayachi, J., Askander, O., El Fahime, E., Fares, H., Ennibi, K., Abouqal, R., Razine, R., Bouhouche, A.
10.1101/2023.08.19.23294314 — Posted: 2023-08-22
Visceral adipose macrophage content does not associate with body mass index or systemic inflammation in COVID-19: an autopsy study
Su, S. H., Nobel, Y. R., Besharati, S., Del Portillo, A., Anderson, M., Freedberg, D. E.
10.1101/2023.08.21.23294361 — Posted: 2023-08-22
No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model.
Reed, D. S., McElroy, A., Barbeau, D., McMillen, C., Tilston-Lunel, N., Nambulli, S., Cottle, E., Gilliland, T., Rannulu, H., Lundy, J., Olsen, E., O'Malley, K., Xia, M., Hartman, A., Luke, T., Egland, K., Bausch, C., Wu, H., Sullivan, E., Klimstra, W., Duprex, P.
10.1101/2023.08.19.553970 — Posted: 2023-08-21
SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain
Halvorson, T., Ivison, S., Huang, Q., Ladua, G., Yotis, D. M., Mannar, D., Subramaniam, S., Ferreira, V. H., Kumar, D., Belga, S., PREVenT Study Group, , Levings, M.
10.1101/2023.08.14.23293991 — Posted: 2023-08-21
Acute renal injury in patients with COVID-19, in the critical care unit of a public hospital, Lima-Peru.
VENEGAS JUSTINIANO, J. Y., HURTADO ARESTEGUI, A., MUCHO VILCA, K.
10.1101/2023.08.20.23294334 — Posted: 2023-08-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).